The human eye long ago solved a problem common to both digital and film cameras: how to get good contrast in an image while also capturing faint detail…
Category: News
Why The Eye Is Better Than A Camera
The human eye long ago solved a problem common to both digital and film cameras: how to get good contrast in an image while also capturing faint detail…
Statement From The American Academy Of Ophthalmology Regarding The Results Of The Comparison Of AMD Treatment Trials
Results of the Comparison of age-related macular degeneration (AMD) Treatment Trials (CATT), a study comparing bevacizumab (Avastin™) and ranibizumab (Lucentis™) in the treatment of neovascular or “wet” AMD, were released today by the National Eye …
Statement From The American Academy Of Ophthalmology Regarding The Results Of The Comparison Of AMD Treatment Trials
Results of the Comparison of age-related macular degeneration (AMD) Treatment Trials (CATT), a study comparing bevacizumab (Avastin™) and ranibizumab (Lucentis™) in the treatment of neovascular or “wet” AMD, were released today by the National Eye …
Patient Group AMD Alliance International Responds To CATT Trials Research
Results of the Comparison of AMD Treatments Trials (CATT) study were published online today in The New England Journal of Medicine (NEJM). The CATT study was designed to compare two drugs currently used to treat wet-AMD: Lucentis (ranibizumab) and Avas…
Patient Group AMD Alliance International Responds To CATT Trials Research
Results of the Comparison of AMD Treatments Trials (CATT) study were published online today in The New England Journal of Medicine (NEJM). The CATT study was designed to compare two drugs currently used to treat wet-AMD: Lucentis (ranibizumab) and Avas…
Association for Research in Vision and Ophthalmology (ARVO) 2011 Annual Meeting
Read clinically focused news coverage of key developments from the meeting. Medscape Ophthalmology
Retina Implant AG Presents Preliminary Results Of Permanently Implanted Patients At The ARVO Annual Meeting
Retina Implant AG, a leading developer of subretinal implants for the visually impaired, today announced the presentation of initial findings from their second clinical trial. Results showed that the first seven patients who were permanently implanted …
SAR 1118 Demonstrates Encouraging Results In Phase 2 Study Of Dry Eye Disease
SARcode Corporation presented data today for their lead investigational molecule, SAR 1118. In a Phase 2 dry eye trial, subjects receiving SAR 1118 demonstrated a reduction in corneal staining, increased tear production, and improved visual-related fun…
Second Sight Announces Significant Results From The Argus? II Retinal Prosthesis Trial At The ARVO 2011 Annual Meeting
Exciting results from the Argus? II Retinal Prosthesis System (‘Argus II’) clinical trial were presented today at the Association for Research in Vision and Ophthalmology, Inc. (ARVO) 2011 Annual Meeting. The clinical trial included 30 subjects implant…
Paulig Eye Surgery Centre First To Offer Innovative Keratoconus Treatment In Germany
The Paulig Eye Surgery Centre announces today that it has acquired advanced technology for performing Keraflex KXL, a new, non-invasive, non-surgical treatment for keratoconus. Surgeons at the Paulig Eye Surgery Centre will immediately begin treating p…
Retina Implant’s second clinical trial initial findings presented at ARVO 2011
Retina Implant AG, a leading developer of subretinal implants for the visually impaired, today announced the presentation of initial findings from their second clinical trial.
Genetic Clue To ‘Emergency’ Glaucoma
Jackson Laboratory researchers and their collaborators have reported their discovery of a gene implicated in an acute and severe form of glaucoma known as angle-closure glaucoma (ACG). The gene’s activity points to previously unsuspected mechanisms inv…
Positive Ellex 2RT Data Demonstrates Efficacy In Treatment Of Early AMD
Ellex Medical Lasers Limited (ASX:ELX), a global leader in ophthalmic technology, today announced milestone clinical results for its breakthrough Retinal Regeneration Therapy (Ellex 2RT™) for the treatment of Early Age-Related Macular Degeneration (A…
Bioptigen Offers Deep Imaging SDOCT For Pre-Clinical Applications
The medical imaging device company, Bioptigen Inc., has created the commercial market’s deepest spectral domain optical coherence tomography (SDOCT) imaging system for pre-clinical applications. Called the Envisu R4300, it is the first Fourier-domain O…
LCA-Vision Announces Management Promotion
LCA-Vision Inc. , a leading provider of laser vision correction services under the LasikPlus® brand, announces the promotion of Marcello J. Celentano to the newly created position of Senior Vice President of Operations, effective May 1, 2011. In his n…
Merck’s Phase III study shows efficacy results of tafluprost to treat ocular hypertension
Merck, known as MSD outside the United States and Canada, announced today that new Phase III data showed that patients with open-angle glaucoma or ocular hypertension, who were dosed once-daily with tafluprost, Merck’s investigational, preservative-fre…
Positive Ellex 2RT Data Demonstrates Efficacy In Treatment Of Early AMD
Adelaide, Australia, 3 May 2011 – Ellex Medical Lasers Limited (ASX:ELX), a global leader in ophthalmic technology, today announced milestone clinical results for its breakthrough Retinal Regeneration Therapy (Ellex 2RTT) for the treatment of Early Age…
Higher BMI In Children Associated With More Rapid Progression Of Diabetic Retinopathy
Overweight or obese children with type 1 diabetes developed diabetic retinopathy more quickly than their leaner counterparts, according to a poster here.
IRIDEX Granted U.S. Patent For Stepped Angled Laser Handpieces Used In Eye Surgery
MOUNTAIN VIEW, Calif., May 2, 2011 — IRIDEX Corporation (Nasdaq: IRIX) today
announced that the U.S. Patent and Trademark Office had issued to IRIDEX a patent
applying to a group of specially designed laser handpieces used in invasive ophthalmic
surgi…